Literature DB >> 12451376

The clinical and histopathologic spectrum of "dermal hypersensitivity reactions," a nonspecific histologic diagnosis that is not very useful in clinical practice, and the concept of a "dermal hypersensitivity reaction pattern".

Maxwell A Fung1.   

Abstract

BACKGROUND: "Dermal hypersensitivity reaction" (DHR) is diagnosed by dermatopathologists but is not an accepted clinical disease entity. There are no clear guidelines for its diagnosis, differential diagnosis, or management.
OBJECTIVES: The objectives were to define the histologic criteria for cases histologically diagnosed as DHR and identify corresponding clinical disorders.
METHODS: Skin biopsy specimens from 130 patients diagnosed as "consistent with DHR" were reviewed. Additional information was obtained from patients, their dermatologists, and medical records.
RESULTS: Follow-up in 74 of 110 patients (median, 26.6 mo) revealed, most commonly, diagnoses of urticaria, drug reactions, and spongiotic (eczematous) dermatitis. Among the remaining cases, 37 of 59 reported persistence of disease, some exhibiting a uniform phenotype characterized by excoriated, edematous papules on the trunk. Histopathologic features present in more than 90% of 143 biopsy specimens included superficial and mid-perivascular lymphocytic infiltrates with eosinophils.
CONCLUSION: DHR is a perivascular lymphocytic dermatitis with eosinophils involving the papillary and upper reticular dermis and minimal, if any, primary epidermal alteration. The term DHR does not represent any known clinical disorder; rather, it corresponds to many clinical disorders. The use of the phrase "dermal hypersensitivity reaction pattern" may be helpful in conveying the idea that a particular histologic pattern may be seen in a number of clinical disorders.

Entities:  

Mesh:

Year:  2002        PMID: 12451376     DOI: 10.1067/mjd.2002.120908

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

Review 1.  Skin Biopsy, the Allergists' Tool: How to Interpret a Report.

Authors:  Brett H Keeling; Aries Caesar P Gavino; Alde Carlo P Gavino
Journal:  Curr Allergy Asthma Rep       Date:  2015-10       Impact factor: 4.806

2.  Cutaneous adverse drug reaction associated with oral temozolomide presenting as dermal and subcutaneous plaques and nodules.

Authors:  Pooja Virmani; Esther Chung; Alissa A Thomas; Ingo K Mellinghoff; Michael A Marchetti
Journal:  JAAD Case Rep       Date:  2015-07-29

3.  A persistent dermal hypersensitivity reaction associated with Helicobacter pylori infection.

Authors:  Cula N Dautriche; Lisa C Zaba; Randie Kim; Shoshana Marmon
Journal:  JAAD Case Rep       Date:  2020-01-30

4.  Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reaction.

Authors:  Norman-Philipp Hoff; Noemi F Freise; Albrecht G Schmidt; Parnian Firouzi-Memarpuri; Julia Reifenberger; Tom Luedde; Edwin Bölke; Stephan Meller; Bernhard Homey; Torsten Feldt; Björn Erik Ole Jensen; Verena Keitel; Livia Schmidt; Kitti Maas; Jan Haussmann; Balint Tamaskovics; Wilfried Budach; Johannes C Fischer; Bettina Alexandra Buhren; Wolfram Trudo Knoefel; Marion Schneider; Peter Arne Gerber; Alessia Pedoto; Dieter Häussinger; Olaf Grebe; Martijn van Griensven; Stephan A Braun; Stefan Salzmann; Amir Rezazadeh; Christiane Matuschek
Journal:  Eur J Med Res       Date:  2021-08-25       Impact factor: 2.175

5.  Six cases of refractory pruritus and histologic dermal hypersensitivity reaction successfully treated with dupilumab.

Authors:  Nicole Edmonds; Margaret Noland; R Hal Flowers
Journal:  JAAD Case Rep       Date:  2021-11-06

6.  An uncommon case of pancreatic adenocarcinoma revealed by dermatitis.

Authors:  Wala Ben Kridis; Afef Khanfir
Journal:  JGH Open       Date:  2022-04-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.